A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angela R Smith, M.D.
Syndax Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peter Maccallum Cancer Centre (pmcc)
Melbourne, Victoria, Australia
Active, not recruiting - Royal Melbourne Hospital (rmh)
Parkville, Victoria, Australia
Active, not recruiting - Alfred Hospital
Melbourne, Australia
Shaun Fleming, MDRecruiting - Sir Charles Gairdner Hospital
Nedlands, Australia
Carolyn Grove, MDRecruiting - Royal North Shore Hospital
Saint Leonards, Australia
Matthew Greenwood, MDRecruiting
- the Hospital for Sick Children
Toronto, Canada
Active, not recruiting - University Health Network
Toronto, Canada
Andre Schuh, MDRecruiting
- Hospital Saint-Louis - Aphp
Paris, France
Emmanuel RaffouxRecruiting - Centre Hospitalier Universitaire (chu) de Bordeaux
Pessac, France
Arnaud PigneuxRecruiting - Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Mael HeibligRecruiting - Institut Gustave Roussy-Gustave Roussy Cancer Center -Ditep
Villejuif, France
Stephanie De BottonRecruiting
- University Hospital of Ulm, Universitatsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Hartmut DoehnerRecruiting - Universitaetsklinikum Essen (aor)
Essen, Germany
Withdrawn - Universitaetsmedizin Greifswald
Greifswald, Germany
Completed - Universitaetsmedizin Der Johannes
Gutenberg, Germany
Michael KuehnRecruiting - Universitaetsklinikum Hamburg-Eppendorf
Hamburg, Germany
Franziska WestendorfRecruiting - University of Leipzig
Leipzig, Germany
Madlen JentzschRecruiting - Klinikum Nuernberg Nord
Nuremberg, Germany
Completed
- Rambam Health Care Campus (rhcc)
Haifa, Israel
Avraham FrischRecruiting - Hadassah Medical Center- Ein Kerem
Jerusalem, Israel
Boaz NachmiasRecruiting - Shaare Zedek Medical Center
Jerusalem, Israel
Yishai OfranRecruiting - Galilee Medical Center
Nahariya, Israel
Galia StemerRecruiting - Rabin Medical Center
Petah Tikva, Israel
Ofir WolachRecruiting - Sheba Medical Center
Ramat Gan, Israel
Irina ArmitaiRecruiting
- Irccs Azienda Ospedaliero Universitaria Di Bologna
Bologna, Italy
Cristina PapayannidisRecruiting - Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori
Meldola, Italy
Irene ZacheoRecruiting - Irccs-Istituto Europeo Di Oncologia
Milan, Italy
Enrico DerenziniRecruiting - Universita Cattolica Fondazione Policlinico Agostino Gemelli
Roma, Italy
Patrizia ChiusoloRecruiting - S Bortolo Hospital Aulss 8 Berica
Vicenza, Italy
Giorgia ScottonRecruiting
- Vilnius University Hospital Santaros Klinikos
Vilnius, Lithuania
Andrius ZucenkaRecruiting
- Princess Maxima Center for Pediatric Oncology
Utrecht, Netherlands
Michael ZwaanRecruiting
- Hospital Centro Comprensivo de Cancer Upr
San Juan, Puerto Rico
Alexis Cruz-ChaconRecruiting
- Institut Catala D'Oncologia (ico) - Hospital Duran I Reynals
L'Hospitalet de Llobregat, Spain
Montserrat Arnan SangermanRecruiting - Hospital Universitario Virgen del Rocio
Seville, Spain
Eduardo Rodriguez-ArboliRecruiting - Hospital Universitari I Politecnic la Fe de Valencia
Valencia, Spain
Pau Montesinos FernandezRecruiting
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
Active, not recruiting - University of California Care Medical Group - Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
Completed - Stanford Cancer Institute
Palo Alto, California, United States
Active, not recruiting - University of Colorado
Aurora, Colorado, United States
Christine McMahonRecruiting - Florida Cancer Specialists and Research Institute
Sarasota, Florida, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Nov 2019
- Primary completion
- 15 Dec 2027
- Completion
- 15 Dec 2027
- Last update posted
- 18 Mar 2026
- Registered enrollment
- 447
- Registry id
- NCT04065399
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.